New hope for kids with arthritis: drug safety study launches

NCT ID NCT06222034

First seen Dec 17, 2025 · Last updated May 16, 2026 · Updated 27 times

Summary

This study is testing an oral medication called filgotinib in 10 children and teens aged 8 to 17 who have juvenile idiopathic arthritis (JIA). The goal is to see how the drug moves through the body and whether it is safe and tolerable. Participants must have moderately to severely active disease not well controlled by current treatments. This is an early-phase study, so it focuses on safety and dosing rather than cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asklepios Klinik Sankt Augustin GmbH

    NOT_YET_RECRUITING

    Sankt Augustin, 53757, Germany

  • Bicêtre University Hospital

    RECRUITING

    Le Kremlin-Bicêtre, 94270, France

  • CHU Amiens - Hopital Nord

    RECRUITING

    Amiens, 80054, France

  • Children's university hospital Charité, Campus Virchow, SPZ

    RECRUITING

    Berlin, 13353, Germany

  • Great Ormond Street Hospital

    NOT_YET_RECRUITING

    London, WC1N 3JH, United Kingdom

  • Hamburger Zentrum fur Kinder und Jugendrheumatologie

    RECRUITING

    Hamburg, 22081, Germany

  • Hospital Sant Joan de Deu

    RECRUITING

    Barcelona, 08950, Spain

  • Hospital Universitari Vall d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitari i Politecnic La Fe

    RECRUITING

    Valencia, 46026, Spain

  • Malopolskie Badania Kliniczne

    RECRUITING

    Krakow, 30-002, Poland

Conditions

Explore the condition pages connected to this study.